Celgene Corp (NASDAQ:CELG)
Robert W Baird Global Healthcare Broker Conference
September 07, 2017, 15:45 ET
Executives
Peter Kellogg - CFO, CAO & Executive VP
Analysts
Brian Skorney - Robert W. Baird & Co.
Brian Skorney
Okay. Good afternoon, everyone. Welcome. I'm Brian Skorney, one of the 2 senior biotech analysts here at Robert Baird. With me, I have the management team of Celgene. Celgene is one of the large-cap names in the biotech space, has had a tremendous success in the development of numerous oncology product. That's been their historical focus. But of late, they've been diversifying into numerous other areas. They have a very deep and diverse pipeline, a number of partnerships. There's way too much to discuss in just a 0.5 hour-setting, but we'll try to do as much as we can.
So Peter, maybe, if you don't mind, maybe you can start by just giving us a brief background on the company and touch on the different franchises you're involved in.
